| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
The primary function of AI in medical imaging is to enhance the accuracy and speed of diagnoses, helping radiologists and other healthcare professionals identify diseases or abnormalities more reliably. AI can analyze medical images (e.g., X-rays, MRIs, CT scans) to detect patterns, highlight areas of concern, and assist in clinical decision-making, ultimately improving patient outcomes. |
Improve diagnostic accuracy and patient outcomes: AI algorithms can detect subtle signs of disease that might be missed by the human eye, reduce diagnostic errors, and provide consistent assessments, which directly impacts patient care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
A key benefit of AI in radiology is that it can act as a second medical opinion for clinicians. AI algorithms analyze medical images and provide an additional assessment, which helps radiologists confirm findings, detect subtle abnormalities, and reduce the risk of diagnostic errors. |
Acts as a second medical opinion: AI does not replace radiologists but supports them by providing an independent analysis of imaging data, improving diagnostic confidence and patient safety. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy refers to a person’s ability to understand, use, and critically evaluate AI technologies. It involves knowing how AI works, its capabilities, limitations, and potential applications, especially in contexts like healthcare or medical imaging. |
Understanding and knowledge of AI technology: Correct—AI literacy emphasizes comprehension of AI concepts, algorithms, and practical uses, rather than technical repair or financial aspects. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the AI machines is clearly irrelevant to the acceptability of AI among healthcare professionals. Acceptability is influenced by more meaningful factors such as trust, understanding, workflow integration, and general openness to technology. |
The color of the AI machines: Not relevant—acceptability depends on functionality and usability, not aesthetics. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence refers to the effect of peers, colleagues, and professional networks on an individual’s behavior. In healthcare, it affects whether professionals are willing to adopt and use AI tools, as opinions and experiences of trusted peers can significantly impact acceptance. |
Affects healthcare professionals’ decisions to use AI: Correct—social influence shapes attitudes and adoption behavior. For example, if respected colleagues trust and use AI, others are more likely to follow. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A perceived threat in AI usage refers to worries or fears that may arise among users about negative consequences. In healthcare, many professionals fear that AI could replace or reduce the role of human clinicians, threatening job security and professional autonomy. |
Concerns about replacing healthcare professionals: Correct—this is a widely reported perceived threat; professionals may worry that AI could take over diagnostic or decision-making tasks. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
The article emphasizes that human-centred AI design is essential for increasing acceptability among medical professionals. This means AI should be user-friendly, integrate smoothly into clinical workflows, and support clinicians rather than replace them, addressing concerns about usability, trust, and professional autonomy. |
Designing human-centred AI systems: Correct—focusing on the needs, workflows, and preferences of healthcare professionals improves adoption and trust. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
The ‘system usage’ category in AI acceptability refers to how the AI system fits into daily clinical practice and how it is perceived to provide value. It includes factors such as the system’s usefulness, relevance to clinical tasks, ease of integration with existing workflows, and overall benefit to the user. |
Factors like value proposition and integration with workflows: Correct—these aspects directly influence whether healthcare professionals will adopt and consistently use the AI system. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethicality impacts AI acceptability because healthcare professionals are more likely to adopt AI systems that align with their ethical standards, professional values, and responsibilities toward patients. If AI decisions or processes conflict with ethical norms (e.g., fairness, transparency, patient safety), acceptance decreases. |
Affects views on AI based on compatibility with professional values: Correct—ethical considerations guide whether clinicians trust and are willing to integrate AI into care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
The article emphasizes that future studies on AI acceptability should focus on user experience and how AI integrates into clinical workflows. Understanding these factors is crucial for adoption because even high-performing AI systems will be rejected if they are difficult to use or disrupt established clinical practices. |
Considering user experience and system integration deeply: Correct—these aspects directly affect practical usability, trust, and adoption among healthcare professionals. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson’s disease is characterized by the progressive loss of dopamine-producing neurons in the substantia nigra region of the brain. The primary objective of using human embryonic stem cells (hESCs) in treatment is to differentiate them into dopamine neurons and replace the neurons that have been lost, thereby restoring dopamine levels and improving motor function. |
To replace lost dopamine neurons: Correct—hESCs can differentiate into the specific type of neurons affected in Parkinson’s disease, addressing the root cause of the motor symptoms. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
The article indicates that monkeys were used in preclinical testing of the STEM-PD product because their brain anatomy and physiology are closer to humans compared to smaller animals like mice or rats. This makes them a more relevant model for assessing safety, efficacy, and potential functional recovery in Parkinson’s disease therapy. |
Monkeys: Correct—non-human primates provide a translational model that closely mimics human Parkinson’s disease pathology and allows better assessment of motor function recovery. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
12 months |
|
The article mentions that a 12-month preclinical safety study in rats was conducted to thoroughly assess the long-term safety of the STEM-PD product. A year-long study allows researchers to observe potential delayed adverse effects, tumor formation, or other chronic safety issues that shorter studies might miss. |
12 months: Correct—this duration is standard for long-term preclinical safety studies in rodents, providing sufficient time to monitor chronic effects. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The article mentions that the STEM-PD clinical trial is at Phase I/IIa, which is typical for first-in-human studies. This combined phase is designed to assess both safety (Phase I) and preliminary efficacy (Phase IIa) of the therapy in a small group of participants. |
Phase I/IIa: Correct—this hybrid phase is common in innovative therapies like stem cell treatments, allowing researchers to evaluate safety while also gathering early data on therapeutic effects. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under non-GMP conditions |
|
The article states that the STEM-PD product is manufactured under Good Manufacturing Practice (GMP)-compliant conditions, which is essential for ensuring product quality, safety, and consistency in clinical-grade stem cell therapies. GMP compliance ensures that the cells are produced in a controlled environment, with standardized procedures and rigorous quality checks. |
Under GMP-compliant conditions: Correct—GMP standards are mandatory for products intended for human clinical trials to guarantee safety and reproducibility. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The article confirms that the safety of the STEM-PD product in rats was demonstrated by the absence of adverse effects, tumor formation, or abnormal responses over the study period. This is a critical step in preclinical testing to ensure the therapy is safe before advancing to human trials. |
There were no adverse effects or tumor formation: Correct—this directly indicates that the product did not cause harmful reactions or uncontrolled cell growth, which is essential for safety validation. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The article reports that in the efficacy study of STEM-PD in rats, the transplanted stem cells successfully differentiated into dopamine neurons and integrated into the brain, leading to a reversal of motor deficits caused by Parkinson’s-like lesions. This demonstrates the therapeutic potential of the product. |
Transplanted cells reversed motor deficits in rats: Correct—this is the primary efficacy endpoint for Parkinson’s models, showing functional recovery. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
The article indicates that the purity of the STEM-PD batch was assessed using the markers FOXA2 and OTX2, which are specific transcription factors expressed in midbrain dopaminergic progenitor cells. These markers confirm that the stem cells were correctly differentiated into the desired dopaminergic lineage before transplantation. |
FOXA2 and OTX2: Correct—these are well-established markers for identifying midbrain dopamine progenitors, ensuring the batch is of high quality and appropriate for Parkinson’s therapy. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
The article explains that growth factors such as FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) are critical in the directed differentiation of human embryonic stem cells. They help pattern the cells into midbrain dopaminergic progenitors, ensuring that the stem cells develop into the specific neural lineage required for Parkinson’s disease therapy. |
They are used in cell patterning for specific neural fates: Correct—FGF8b and SHH provide molecular cues that guide stem cells toward a midbrain dopaminergic identity. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
The article emphasizes that the preclinical efficacy trials in rats focused on Parkinson’s disease–like motor deficits. The primary outcome measured was whether transplanted STEM-PD cells could restore motor function, which is directly related to the loss of dopaminergic neurons in Parkinson’s disease. |
Recovery of motor function: Correct—Parkinson’s disease primarily affects motor abilities, so improvement in motor performance is the most relevant efficacy measure. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|